Iron-balance and dose-response studies of the oral iron chelator 1,2- dimethyl-3-hydroxypyrid-4-one (L1) in iron-loaded patients with sickle cell diseaseAF Collins, NF Olivieri, Marilyn Fry et al.|Blood|1994Cited by 84